Epidemiology of extracutaneous melanoma in the Netherlands
- PMID: 20501769
- DOI: 10.1158/1055-9965.EPI-09-1267
Epidemiology of extracutaneous melanoma in the Netherlands
Abstract
Background: Reliable population-based incidence and survival data on extracutaneous melanoma (ECM) are sparse.
Methods: Incidence data (1989-2006) from the Netherlands Cancer Registry were combined with vital status on January 1, 2008. Age-adjusted annual incidence rates were calculated by direct standardization, and the estimated annual percentage change was estimated to detect changing trends in incidence. Additionally, we carried out cohort-based relative survival analysis.
Results: Ocular melanomas were the most common ECM subsite with European standardized incidence rates (ESR) of 10.7 and 8.2 per 1,000,000 person-years for males and females, respectively. In comparison, for cutaneous melanoma (CM), the ESRs for men and women were 122 and 155 per million person-years, respectively. No statistically significant trends in the incidence of ECM were detected, whereas an annual increase of 4.4% for men and 3.6% for women was detected in the incidence of CM. Relative survival for ECM was poor, but differed largely between anatomic subtypes ranging from a 5-year relative survival of 74% for ocular melanomas to 15% for certain subsites of mucosal melanomas.
Conclusions: Of all ECM subsites, ocular melanomas had the highest incidence and the best survival. Mucosal melanomas were the second most frequent subsite of ECM. Five-year relative survival for all ECM subtypes was worse if compared with CM. No statistically significant trends in the incidence of (subsites of) ECM were determined.
Impact: This study gives insight into the relative sizes of the different subgroups of ECM as well as an estimate of 5-year survival, which varies substantially by subsite.
Copyright 2010 AACR.
Similar articles
-
Incidence of noncutaneous melanomas in the U.S.Cancer. 2005 Mar 1;103(5):1000-7. doi: 10.1002/cncr.20866. Cancer. 2005. PMID: 15651058
-
Invasive cutaneous melanoma in The Netherlands, 1989-1990.Eur J Cancer Prev. 1996 Feb;5(1):69-74. Eur J Cancer Prev. 1996. PMID: 8664813
-
A population-based study of cutaneous melanoma in Alberta, Canada (1993-2002).J Am Acad Dermatol. 2010 Feb;62(2):227-32. doi: 10.1016/j.jaad.2009.01.047. Epub 2009 Dec 16. J Am Acad Dermatol. 2010. PMID: 20018405
-
Cutaneous melanoma.Cancer Surv. 1994;19-20:219-40. Cancer Surv. 1994. PMID: 7534627 Review.
-
Ocular melanoma in childhood.Aust N Z J Surg. 1993 Sep;63(9):729-31. doi: 10.1111/j.1445-2197.1993.tb00502.x. Aust N Z J Surg. 1993. PMID: 8363486 Review.
Cited by
-
Clinics, prognosis and new therapeutic options in patients with mucosal melanoma: A retrospective analysis of 75 patients.Medicine (Baltimore). 2017 Jan;96(1):e5753. doi: 10.1097/MD.0000000000005753. Medicine (Baltimore). 2017. PMID: 28072717 Free PMC article.
-
Predictors of mucosal melanoma survival in a population-based setting.J Am Acad Dermatol. 2019 Jul;81(1):136-142.e2. doi: 10.1016/j.jaad.2018.09.054. Epub 2018 Oct 5. J Am Acad Dermatol. 2019. PMID: 30296542 Free PMC article.
-
Mucosal melanomas in the racially diverse population of California.J Am Acad Dermatol. 2017 Feb;76(2):250-257. doi: 10.1016/j.jaad.2016.08.007. Epub 2016 Oct 11. J Am Acad Dermatol. 2017. PMID: 27742175 Free PMC article.
-
Outcome after therapeutic lymph node dissection in patients with unknown primary melanoma site.Ann Surg Oncol. 2011 Dec;18(13):3586-92. doi: 10.1245/s10434-011-1801-5. Epub 2011 May 25. Ann Surg Oncol. 2011. PMID: 21611857 Free PMC article.
-
Melanoma of the oral cavity: pathogenesis, dermoscopy, clinical features, staging and management.J Dermatol Case Rep. 2014 Sep 30;8(3):60-6. doi: 10.3315/jdcr.2014.1175. eCollection 2014 Sep 30. J Dermatol Case Rep. 2014. PMID: 25324906 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous